IL-12/IL-23 p40 Antikörper
-
- Target Alle IL-12/IL-23 p40 Produkte
- IL-12/IL-23 p40
-
Reaktivität
- Human
-
Wirt
- Maus
-
Klonalität
- Monoklonal
-
Konjugat
- Dieser IL-12/IL-23 p40 Antikörper ist unkonjugiert
-
Applikation
- Neutralization (Neut)
- Spezifität
- Native and recombinant p40 subunit of human IL-12 and IL-23
- Aufreinigung
- Purified from in vitro cultures by protein G affinity chromatography.
- Immunogen
- Recombinant human IL-23
- Klon
- MT3279H
- Isotyp
- IgG2b
-
-
- Applikationshinweise
- Neutralization of human IL-12 and IL-23 bioactivity. It is recommended to establish the optimal antibody concentration for the assay system used. Neutralization Neutralization assay: Neutralization of human IL-12 and human IL-23 induced IFN-γ production (see graphs). To determine the neutralizing capacity and ND50 on IL-12 induced IFN-γ production, mixtures of various concentrations of mAb MT3279H, human recombinant IL-12 (10 ng/mL) and recombinant IL-1β (50 ng/mL) were added to human PBMC. For determination of the neutralizing capacity and ND50 on IL-23 induced IFN-γ production, mixtures of various concentrations of mAb MT3279H, human recombinant IL-23 (10 ng/ ml) and recombinant IL-18 (50 ng/mL) were added to human PBMC. Following overnight incubation, cell supernatants were quantified in IFN-γ ELISA. Neutralization dose 50 (ND50): MT3279H neutralized the effect of IL-12 and IL-23 at a ND50value of 0.2-0.5 μg/mL when 10 ng/mL of recombinant human IL-12 or IL-23 was present. ND50 is defined as the concentration of antibody that results in 50 % inhibition of the biological response under the experimental conditions specified.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Konzentration
- 1 mg/mL
- Buffer
- supplied at 1 mg/mL in PBS free of preservatives
- Konservierungsmittel
- Without preservative
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store product at 4-8°C or frozen at -20°C or below. Avoid repeated freezing/thawing.
- Haltbarkeit
- 18 months
-
-
Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells." in: Journal of virology, Vol. 87, Issue 24, pp. 13446-55, (2014) (PubMed).
: "
-
Epstein-Barr virus coinfection in children boosts cytomegalovirus-induced differentiation of natural killer cells." in: Journal of virology, Vol. 87, Issue 24, pp. 13446-55, (2014) (PubMed).
-
- Target
- IL-12/IL-23 p40
- Andere Bezeichnung
- IL12/23 (p40) (IL-12/IL-23 p40 Produkte)
- Gen-ID
- 3592, 3593
-